About This Study
The purpose of this 6-week study is to explore new treatment options for people with depression. The study will help determine the best dose of an FDA-approved medication that might be used in the future to treat sub-groups of depressed individuals.
The study will have 2-3 screening visits (online and in-person) that includes lab tests, medical and psychiatric assessments, neurocognitive testing and functional MRI (fMRI) scans as part of the study. The total length of participation is about 2 months.
Compensation is provided. Enroll today!